Market Place
Sourcing Support
Mylan’s Generics Aprepitant Receives Approval in US
05 Mar 2026 //
FDA
Mylan’s Generics Rifaximin Receives Tentative Approval in US
07 Jan 2026 //
FDA
Mylan’s Generics Octreotide Acetate Receives Approval in US
12 Dec 2025 //
FDA
Mylan’s Generics Macitentan Receives Approval in US
03 Dec 2025 //
FDA
Mylan’s Generics Aprepitant Receives Tentative Approval in US
17 Nov 2025 //
FDA
Viatris Pharma`s Nintedanib Viatris Receives Approval in Europe
22 Aug 2025 //
EMA
Viatris’ Emtricitabine Rilpivirine Receives Approval In Europe
19 Aug 2025 //
EMA
Mylan’s Receives First Generic Approval for Iron Sucrose in US
08 Aug 2025 //
FDA
Mylan’s Receives First Generic Approval for Darunavir in US
22 Jul 2025 //
FDA
Mylan Pharma`s Biologic Hulio Receives Suppl Approval in US
05 Feb 2025 //
FDA
Mylan`s Generics Dabigatran Receives Approval in US
03 Feb 2025 //
FDA
Mylan`s Generics Glucagon Receives Approval in US
12 Dec 2024 //
FDA
Mylan Pharma`s Biologic Semglee Receives Suppl Approval in US
25 Nov 2024 //
FDA
Mylan`s Generics Sugammadex Receives Tentative Approval in US
20 Nov 2024 //
FDA
Mylan Pharms Generic Aripiprazole Receives Tentative Approval in US
27 Jun 2024 //
FDA
Mylan`s Generic Deferasirox Receives Approval in the U.S.
17 May 2024 //
FDA
Mylan`s Generic Deferasirox Receives Approval in the U.S.
03 May 2024 //
FDA
Mylan`s Generic Darunavir Receives Tentative Approval in the U.S.
26 Mar 2024 //
FDA
Mylan`s Generic Lopinavir and Ritonavir Receives Approval in the U.S.
07 Feb 2024 //
FDA
Mylan`s Generic Cobicistat Receives Approval in the U.S.
07 Feb 2024 //
FDA
Mylan`s Biologic Hulio (adalimumab) Receives Approval in the U.S.
15 Dec 2023 //
FDA
Viatris` Rivaroxaban Receives Approval in Europe
13 Dec 2023 //
EMA
Mylan`s Biologic Fulphila (pegfilgrastim) Receives Approval in the U.S.
13 Oct 2023 //
FDA
Mylan`s Generic Rivaroxaban Receives Approval in the U.S.
14 Aug 2023 //
FDA
Mylan`s Generic Daptomycin Receives Approval in the U.S.
07 Aug 2023 //
FDA
Mylan`s Abiraterone Acetate Receives Approval in Europe
18 Jul 2023 //
EMA
Mylan`s Generic Cabazitaxel Receives Approval in the U.S.
05 Jul 2023 //
FDA
Mylan`s Generic (Posaconazole) Receives Approval in the U.S.
21 Jun 2023 //
FDA
Mylan`s Generic Sugammadex Sodium Receives Approval in the U.S.
15 Jun 2023 //
FDA
Mylan`s Biologic Semglee(Insulin Glargine) Receives Approval in the U.S.
30 May 2023 //
FDA
Mylan`s Generic Docetaxel Receives Receives Approval in the U.S.
11 May 2023 //
FDA
Mylan`s Generic Regadenoson MonohydrateReceives Approval in the U.S.
04 Apr 2023 //
FDA
Viatris` Dapagliflozin Receives Approval in Europe
04 Apr 2023 //
EMA
Mylan`s Generic Lenalidomide Receives Approval in the U.S.
06 Mar 2023 //
FDA
Viatris`s Pirfenidone Receives Approval in Europe
17 Jan 2023 //
EMA
Viatris`s Pirfenidone Viatris (pirfenidone) Receives Approval in Europe
17 Jan 2023 //
EMA
Mylan`s Generic Lenalidomide Receives Approval in the U.S.
14 Dec 2022 //
FDA
Mylan`s Generic Triamcinolone Acetonide Receives Approval in the U.S.
02 Nov 2022 //
FDA
Mylan`s Generic Voriconazole Receives Approval in the U.S.
11 Oct 2022 //
FDA
Mylan`s Generic Sucralfate Receives Approval in the U.S.
12 Sep 2022 //
FDA
Mylan`s Generic Carafate, Sucralfate Receives Approval in the U.S.
12 Sep 2022 //
FDA
Mylan`s Generic Lenalidomide Receives Approval in the U.S.
30 Aug 2022 //
FDA
Mylan Generic Fingolimod HCL Receives Tentative Approval in the U.S.
15 Jul 2022 //
FDA
Mylan Inc Hulio Adalimumab Receives Approval in US
14 Jul 2022 //
FDA
Mylan Labs Generic Naloxone Hydrochloride Receives Approval in the U.S.
09 Jun 2022 //
FDA
Mylan Labs Generic Brivaracetam Receives Approval in the U.S.
07 Jun 2022 //
FDA
Mylan Ireland Generic Dimethyl fumarate Receives Approval in Europe
25 May 2022 //
EMA
Mylan Tech Viatris` Generic Methylphenidate Receives Approval in the U.S.
14 Mar 2022 //
FDA
Mylan`s Generics Sitagliptin & Metformin HCl Receives Approval in Europe
08 Mar 2022 //
EMA
Mylan`s Generic Dapsone Receives Approval in the U.S.
04 Feb 2022 //
FDA
Mylan`s Generic Cyclosporine Receives Approval in the U.S.
02 Feb 2022 //
FDA
Mylan`s Generic Pomalidomide Receives Approval in the U.S.
26 Jan 2022 //
FDA
Mylan`s Generic Valproate Sodium Receives Approval in the U.S.
22 Dec 2021 //
FDA
Biogen`s Biologic Tysabri (Natalizumab) Receives Approval in the U.S.
10 Dec 2021 //
FDA
Mylan`s Generic Sunitib Maleate Receives Approval in the U.S.
06 Dec 2021 //
FDA
Mylan`s Sugammadex Mylan (sugammadex sodium) Receives Approval in Europe
22 Nov 2021 //
EMA
Mylan`s Generic Pregabalin Receives Approval in the US
03 Nov 2021 //
FDA
Mylan`s Fingolimod Mylan (fingolimod)Receives Approval in Europe
31 Aug 2021 //
EMA
